
  
    
      
        Background_NNP
        Cells_NNP of_IN the_DT innate_JJ immune_JJ system_NN sense_NN host_NN invasion_NN by_IN
        detecting_VBG structural_JJ determinants_NNS that_WDT are_VBP broadly_RB
        conserved_JJ among_IN pathogens_NNS of_IN a_DT given_VBN phylogenetic_JJ group_NN [_NN
        1_CD ]_NN ._. The_DT lipopolysaccharides_NNS (_( LPS_NNP or_CC endotoxin_NN )_) that_DT
        decorate_NN the_DT outer_JJ membrane_NN of_IN Gram-negative_NNP bacteria_NNS are_VBP
        excellent_JJ examples_NNS of_IN such_JJ determinants_NNS ._. In_IN response_NN to_TO
        minute_NN concentrations_NNS of_IN LPS_NNP derived_VBD from_IN certain_JJ
        Gram-negative_NNP bacteria_NNS ,_, macrophages_NNS secrete_NN cytokines_NNS such_JJ
        as_IN tumor_NN necrosis_NNS factor_NN (_( TNF_NNP )_) ,_, interleukin-_NN 1_CD (_( IL-_NNP 1_LS )_) and_CC
        IL-_NNP 6_CD ,_, which_WDT contribute_VBP to_TO the_DT containment_NN of_IN infection_NN and_CC
        help_VB to_TO initiate_VB a_DT specific_JJ immune_JJ response_NN ._. On_IN the_DT other_JJ
        hand_NN ,_, overstimulation_NN of_IN the_DT innate_JJ immune_JJ system_NN through_IN
        this_DT channel_NN can_MD lead_VB to_TO acute_JJ systemic_JJ inflammation_NN and_CC
        shock_NN [_NN 2_CD ,_, 3_CD ]_NN ._.
        Dramatic_NNP differences_NNS in_IN LPS_NNP responses_NNS are_VBP apparent_JJ
        between_IN closely_RB related_VBN species_NNS [_NN 4_CD ]_NN ,_, and_CC there_EX are_VBP
        substantial_JJ differences_NNS even_RB among_IN genetically_RB
        heterogeneous_JJ members_NNS of_IN the_DT same_JJ species_NNS [_NN 5_CD ]_NN ._. For_IN
        example_NN ,_, whereas_IN humans_NNS and_CC chimpanzees_NNS are_VBP generally_RB
        considered_VBN to_TO be_VB very_RB sensitive_JJ to_TO LPS_NNP [_NN 4_CD ]_NN ,_, baboons_NNS and_CC
        most_RBS other_JJ primates_NNS are_VBP highly_RB resistant_JJ ._. It_PRP is_VBZ likely_JJ that_DT
        part_NN of_IN the_DT difference_NN in_IN sensitivity_NN may_MD be_VB explained_VBN at_IN a_DT
        very_JJ proximal_NN level_NN ,_, although_IN differences_NNS in_IN responses_NNS to_TO
        cytokines_NNS (_( for_IN example_NN TNF_NNP )_) may_MD also_RB have_VB a_DT role_NN ._. Neither_DT
        interspecific_JJ differences_NNS nor_CC interindividual_NN differences_NNS
        in_IN LPS_NNP responses_NNS have_VBP ,_, until_IN recently_RB ,_, been_VBN accessible_JJ to_TO
        systematic_JJ genetic_JJ analysis_NN ._. Advances_NNS in_IN understanding_NN LPS_NNP
        signal_NN transduction_NN now_RB permit_VB these_DT issues_NNS to_TO be_VB
        examined_VBN ._.
        Although_IN LPS_NNP was_VBD once_RB thought_VBN to_TO exert_VB its_PRP$ effects_NNS
        through_IN intercalation_NN into_IN biological_JJ membranes_NNS ,_, or_CC to_TO bind_NN
        to_TO many_JJ different_JJ receptors_NNS on_IN the_DT cell_NN surface_NN ,_, it_PRP has_VBZ
        been_VBN clear_JJ for_IN nearly_RB three_CD decades_NNS that_IN there_EX is_VBZ ,_, in_IN fact_NN ,_,
        a_DT single_JJ biochemical_JJ pathway_NN for_IN LPS_NNP detection_NN ._. This_DT was_VBD
        indicated_VBN by_IN the_DT observation_NN that_IN allelic_JJ [_NN 6_CD ]_NN mutations_NNS of_IN
        a_DT single_JJ gene_NN (_( 
        Lps_NNP )_) in_IN mice_NNS could_MD entirely_RB abrogate_NN
        the_DT response_NN to_TO LPS_NNP ,_, and_CC did_VBD so_RB with_IN great_JJ specificity_NN ._.
        Mice_NNS of_IN the_DT strains_NNS C_NNP 3_CD H_NNP /_NN HeJ_NNP [_NN 7_CD ]_NN and_CC C_NNP 57_CD BL_NNP /_NN 10_CD ScCr_NNP [_NN 8_CD ]_NN are_VBP
        highly_RB resistant_JJ to_TO LPS_NNP ,_, showing_VBG none_NN of_IN the_DT usual_JJ
        biological_JJ effects_NNS ,_, yet_RB respond_VB normally_RB to_TO other_JJ bacterial_JJ
        products_NNS and_CC to_TO most_JJS cytokines_NNS induced_VBN by_IN LPS_NNP [_NN 9_CD ]_NN ._.
        We_PRP recently_RB identified_VBD the_DT 
        Lps_NNP locus_JJ through_IN positional_JJ cloning_VBG
        [_NN 10_CD ]_NN and_CC showed_VBD that_IN the_DT LPS-resistance_NNP phenotype_NN was_VBD
        caused_VBN by_IN defects_NNS in_IN the_DT Toll-like_NNP receptor_NN 4_CD gene_NN (_( 
        Tlr_NNP 4_LS )_) [_NN 11_CD ]_NN ._. In_IN C_NNP 3_CD H_NNP /_NN HeJ_NNP mice_NNS ,_, a_DT
        point_NN mutation_NN (_( P_NN 712_CD H_NNP ;_: single-letter_JJ amino-acid_JJ notation_NN )_)
        modifies_VBZ the_DT protein_NN within_IN the_DT cytoplasmic_JJ domain_NN ,_,
        creating_VBG a_DT codominant_NN inhibitory_NN effect_NN on_IN LPS_NNP signal_NN
        transduction_NN ._. In_IN C_NNP 57_CD BL_NNP /_NN 10_CD ScCr_NNP mice_NNS the_DT gene_NN is_VBZ deleted_VBN ,_,
        yielding_VBG a_DT recessive_JJ abolition_NN of_IN the_DT LPS_NNP response_NN ._.
        Subsequently_RB ,_, overexpression_NN of_IN the_DT wild-type_JJ Tlr_NNP 4_CD protein_NN
        was_VBD found_VBN to_TO enhance_VB LPS_NNP signal_NN transduction_NN in_IN wild-type_JJ
        macrophages_NNS ,_, lowering_VBG the_DT effective_JJ concentration_NN (_( EC_NNP 
        50_CD )_) for_IN LPS_NNP by_IN a_DT factor_NN of_IN 30_CD ,_, whereas_IN
        overexpression_NN of_IN the_DT Tlr_NNP 4_CD Lps-disoform_NNP represented_VBD in_IN
        C_NNP 3_CD H_NNP /_NN HeJ_NNP mice_NNS almost_RB completely_RB suppresses_NNS signaling_VBG [_NN 12_CD ]_NN ._.
        Furthermore_RB ,_, genetic_JJ complementation_NN studies_NNS have_VBP
        demonstrated_VBN that_IN LPS_NNP and_CC Tlr_NNP 4_CD enter_VB into_IN close_JJ physical_JJ
        proximity_NN in_IN the_DT course_NN of_IN signal_NN transduction_NN -_: Tlr_NNP 4_CD
        appears_VBZ to_TO bind_NN directly_RB to_TO LPS_NNP ._. Hence_RB ,_, the_DT species_NNS origin_NN
        of_IN Tlr_NNP 4_CD is_VBZ the_DT sole_JJ determinant_NN of_IN species_NNS preference_NN for_IN a_DT
        given_VBN LPS_NNP structure_NN [_NN 13_CD ]_NN ._.
        Mice_NNS of_IN the_DT C_NNP 3_CD H_NNP /_NN HeJ_NNP and_CC C_NNP 57_CD BL_NNP /_NN 10_CD ScCr_NNP strains_NNS are_VBP
        abnormally_RB susceptible_JJ to_TO infection_NN by_IN certain_JJ
        Gram-negative_NNP bacteria_NNS ,_, suggesting_VBG that_IN timely_JJ recognition_NN
        of_IN LPS_NNP is_VBZ essential_JJ for_IN successful_JJ containment_NN of_IN infection_NN
        [_NN 14_CD ,_, 15_CD ]_NN ._. Because_IN deleterious_JJ mutations_NNS of_IN 
        Tlr_NNP 4_CD have_VBP become_VBN fixed_VBN spontaneously_RB
        in_IN two_CD strains_NNS of_IN mice_NNS ,_, we_PRP considered_VBD it_PRP possible_JJ that_IN
        other_JJ functionally_RB important_JJ mutations_NNS might_MD be_VB identified_VBN
        in_IN mice_NNS and_CC humans_NNS ._. Moreover_RB ,_, information_NN on_IN the_DT degree_NN of_IN 
        Tlr_NNP 4_CD polymorphism_NN in_IN these_DT and_CC other_JJ
        species_NNS might_MD allow_VB inferences_NNS about_IN the_DT importance_NN of_IN
        different_JJ Tlr_NNP 4_CD domains_NNS ._. Accordingly_RB ,_, we_PRP decided_VBD to_TO sequence_NN
        the_DT entire_JJ Tlr_NNP 4_CD gene_NN of_IN both_DT humans_NNS and_CC mice_NNS ,_, and_CC to_TO survey_VB
        genetic_JJ variation_NN at_IN the_DT locus_JJ in_IN each_DT species_NNS ._. We_PRP also_RB
        examined_VBD the_DT 
        TLR_NNP 4_CD sequence_NN from_IN two_CD species_NNS of_IN
        subhuman_NN primates_NNS that_WDT have_VBP dramatically_RB different_JJ
        responses_NNS to_TO LPS_NNP ._.
      
      
        Results_NNS
        
          Overall_RB structure_NN of_IN TLR_NNP 4_CD sand_NN Tlr_NNP 4_CD
          The_DT mouse_NN 
          Tlr_NNP 4_CD gene_NN is_VBZ somewhat_RB longer_RBR than_IN
          its_PRP$ human_JJ counterpart_NN 
          TLR_NNP 4_CD ,_, owing_VBG to_TO the_DT greater_JJR length_NN
          of_IN intronic_JJ sequence_NN -_: 15_CD ,_, 337_CD base_NN pairs_NNS (_( bp_NN )_) from_IN
          beginning_VBG to_TO end_NN of_IN the_DT transcribed_JJ sequence_NN in_IN the_DT
          mouse_NN ,_, compared_VBN with_IN 11_CD ,_, 467_CD bp_NN in_IN the_DT human_NN ._. There_EX are_VBP
          three_CD exons_NNS in_IN 
          Tlr_NNP 4_CD ,_, and_CC each_DT corresponds_NNS to_TO a_DT
          homologous_RB sequence_NN in_IN the_DT human_JJ gene_NN ._. Rock_NNP 
          et_CC al_NN ._. [_NN 16_CD ]_NN reported_VBD a_DT human_JJ cDNA_NN
          sequence_NN (_( GenBank_NNP accession_NN number_NN U_NNP 88880_CD )_) that_WDT includes_VBZ
          a_DT fourth_JJ exon_NN ,_, positioned_VBN between_IN the_NNP '_POS normal_JJ '_POS first_JJ and_CC
          second_JJ introns_NNS ._. When_WRB included_VBN in_IN the_DT processed_VBN
          transcript_NN ,_, however_RB ,_, this_DT exon_NN specifies_VBZ early_JJ
          termination_NN of_IN the_DT polypeptide_NN chain_NN ._. Although_IN it_PRP is_VBZ
          possible_JJ that_DT translation_NN is_VBZ initiated_VBN distal_NN to_TO the_DT
          added_VBD stop_NN codon_NN ,_, and_CC that_IN a_DT shorter_JJR product_NN results_NNS in_IN
          the_DT human_NN than_IN in_IN the_DT mouse_NN ,_, this_DT would_MD be_VB unusual_JJ ,_, given_VBN
          the_DT length_NN of_IN the_DT 5_CD '_POS untranslated_JJ region_NN (_( UTR_NNP )_) that_WDT would_MD
          then_RB exist_VB and_CC the_DT presence_NN of_IN multiple_JJ upstream_RB
          initiation_NN codons_NNS ._. Moreover_RB ,_, there_EX is_VBZ no_DT murine_NN sequence_NN
          homologous_RB to_TO the_DT alternative_NN second_JJ exon_NN of_IN the_DT human_JJ
          gene_NN ._. The_DT biological_JJ significance_NN of_IN this_DT exon_NN is_VBZ
          therefore_RB unclear_JJ and_CC ,_, in_IN all_DT likelihood_NN ,_, its_PRP$ inclusion_NN
          in_IN the_DT mRNA_NN leads_VBZ to_TO the_DT formation_NN of_IN a_DT nonfunctional_NN
          protein_NN ._.
          Neither_DT the_DT human_JJ nor_CC the_DT mouse_NN gene_NN has_VBZ a_DT TATA_NNP
          element_NN or_CC CAAT_NNP box_NN in_IN the_DT proximal_NN promoter_NN region_NN ._. A_DT
          number_NN of_IN conserved_JJ promoter_NN and_CC enhancer_NN motifs_NNS are_VBP
          apparent_JJ on_IN alignment_NN of_IN the_DT murine_NN and_CC human_JJ 5_CD '_POS flanking_VBG
          sequences_NNS ,_, and_CC are_VBP described_VBN in_IN detail_NN elsewhere_RB [_NN 17_CD ]_NN ._.
          Both_DT 
          Tlr_NNP 4_CD and_CC 
          TLR_NNP 4_CD lie_VB amid_IN repetitive_JJ sequences_NNS
          of_IN retroviral_NN origin_NN ,_, and_CC no_DT other_JJ genes_NNS are_VBP detected_VBN
          close_RB to_TO either_CC of_IN them_PRP using_VBG homology_NN searches_NNS or_CC the_DT
          gene_NN prediction_NN algorithm_NN GRAIL_NNP ._. In_IN Figure_NN 1_CD ,_, the_DT
          grayscale_NN images_NNS of_IN the_DT human_NN and_CC mouse_NN genes_NNS call_VBP
          attention_NN to_TO the_DT repetitive_JJ elements_NNS in_IN the_DT region_NN and_CC
          illustrate_VBP the_DT relationship_NN between_IN exons_NNS and_CC spacing_VBG in_IN
          the_DT two_CD species_NNS ._.
        
        
          Genetic_JJ variation_NN at_IN the_DT mouse_NN Tlr_NNP 4_CD locus_JJ
          Among_IN 35_CD strains_NNS of_IN 
          Mus_NNP musculus_JJ ,_, 10_CD different_JJ alleles_NNS
          were_VBD identified_VBN on_IN the_DT basis_NN of_IN mutations_NNS at_IN 22_CD sites_NNS
          with_IN respect_NN to_TO the_DT reference_NN sequence_NN ._. Of_IN these_DT ,_, 13_CD
          create_VB amino-acid_JJ substitutions_NNS (_( Table_NNP 1_CD ,_, Figure_NN 2_LS )_) ._. The_DT
          most_RBS common_JJ murine_NN allele_NN was_VBD represented_VBN at_IN a_DT frequency_NN
          of_IN only_RB 69_CD %_NN ._. The_DT ancestry_NN of_IN different_JJ 
          Tlr_NNP 4_CD alleles_NNS can_MD be_VB traced_VBN by_IN
          haplotype_NN analysis_NN ,_, as_IN many_JJ deviations_NNS from_IN the_DT reference_NN
          allele_NN occur_VB in_IN conjunction_NN with_IN one_CD another_DT ._. A_DT plausible_JJ
          arrangement_NN of_IN strain_NN relationships_NNS is_VBZ presented_VBN in_IN
          Figure_NN 3_CD ._. Some_DT strains_NNS have_VBP accumulated_VBN many_JJ more_JJR
          mutations_NNS than_IN others_NNS ._. For_IN example_NN ,_, the_DT P_NN /_NN J_NNP strain_NN 
          Tlr_NNP 4_CD gene_NN exhibits_VBZ 11_CD mutations_NNS the_DT
          distinguish_VB it_PRP from_IN the_DT most_RBS common_JJ haplotype_NN ,_, six_CD of_IN
          them_PRP specifying_VBG changes_NNS in_IN the_DT Tlr_NNP 4_CD amino-acid_JJ sequence_NN ;_:
          the_DT SEA_NNP /_NN GnJ_NNP strain_NN differs_VBZ by_IN nine_CD mutations_NNS ,_, and_CC the_DT
          strains_NNS NZW_NNP /_NN J_NNP and_CC VM_NNP /_NN Dk_NNP ,_, which_WDT are_VBP identical_JJ to_TO one_CD
          another_DT ,_, differ_VB from_IN the_DT most_RBS common_JJ haplotype_NN at_IN six_CD
          sites_NNS ._. Shared_NNP mutations_NNS suggest_VBP that_DT introgression_NN took_VBD
          place_NN after_IN mutational_NN separation_NN had_VBD occurred_VBN ,_, leading_VBG
          to_TO the_DT introduction_NN of_IN groups_NNS of_IN mutations_NNS by_IN genetic_JJ
          recombination_NN ._. Hence_RB ,_, mice_NNS of_IN the_DT P_NN /_NN J_NNP ,_, NZW_NNP /_NN J_NNP ,_, and_CC VM_NNP /_NN Dk_NNP
          strains_NNS have_VBP several_JJ mutations_NNS that_WDT are_VBP observed_VBN in_IN the_DT
          A_DT /_NN J_NNP and_CC BALB_NNP /_NN c_SYM strains_NNS ,_, but_CC also_RB lack_NN some_DT of_IN the_DT
          mutations_NNS of_IN the_DT latter_JJ strains_NNS and_CC have_VBP unique_JJ mutations_NNS
          of_IN their_PRP$ own_JJ ._.
          Most_JJS of_IN the_DT murine_NN mutations_NNS reside_VB within_IN exon_NN 3_CD ,_, and_CC
          only_RB two_CD substitutions_NNS are_VBP noted_VBN that_WDT modify_VB the_DT
          cytoplasmic_JJ domain_NN (_( Figure_NN 2_CD ._. )_) Of_IN these_DT ,_, however_RB ,_, one_CD
          mutation_NN (_( R_NN 761_CD H_NNP )_) is_VBZ fairly_RB common_JJ among_IN the_DT strains_NNS
          surveyed_VBN ,_, and_CC the_DT corresponding_JJ residue_NN has_VBZ been_VBN reported_VBN
          as_IN an_DT H_NNP in_IN the_DT hamster_NN ._. A_DT single_JJ conservative_JJ
          substitution_NN (_( V_NNP 637_CD I_PRP )_) was_VBD noted_VBN within_IN the_DT transmembrane_NN
          domain_NN of_IN the_DT P_NN /_NN J_NNP strain_NN ._.
        
        
          Anthropoid_NNP ape_NN and_CC lower_JJR primate_NN TLR_NNP 4_CD sequences_NNS ,_, and_CC
          their_PRP$ relationship_NN to_TO the_DT human_NN and_CC rodent_NN
          sequences_NNS
          The_DT human_NN and_CC chimpanzee_NN amino-acid_JJ sequences_NNS are_VBP
          nearly_RB identical_JJ over_IN the_DT interval_NN studied_VBD ,_, distinguished_VBN
          by_IN only_RB three_CD substitutions_NNS ._. The_DT baboon_NN sequence_NN is_VBZ 93_CD ._. 5_LS %_NN
          identical_JJ to_TO the_DT human_NN in_IN the_DT extracellular_NN domain_NN ,_,
          differs_VBZ in_IN the_DT transmembrane_NN domain_NN by_IN one_CD substitution_NN
          out_IN of_IN 30_CD residues_NNS ,_, and_CC differs_VBZ in_IN the_DT proximal_NN
          cytoplasmic_JJ domain_NN by_IN only_RB one_CD residue_NN in_IN 155_CD ._. At_IN the_DT
          carboxyl_NN terminus_JJ ,_, however_RB ,_, homology_NN is_VBZ badly_RB disrupted_VBN ,_,
          so_IN that_IN 16_CD of_IN the_DT last_JJ 21_CD human_JJ residues_NNS are_VBP not_RB
          replicated_VBN in_IN the_DT baboon_NN protein_NN ,_, which_WDT is_VBZ 13_CD amino_JJ acids_NNS
          shorter_JJR than_IN the_DT human_JJ protein_NN ._. Similarly_RB ,_, among_IN rodents_NNS ,_,
          the_DT carboxyl_NN terminus_JJ of_IN the_DT protein_NN is_VBZ the_DT least_JJS
          conserved_JJ ._. Overall_RB ,_, the_DT order_NN of_IN conservation_NN with_IN
          respect_NN to_TO domain_NN is_VBZ :_: proximal_NN cytoplasmic_JJ domain_NN >_NN
          transmembrane_NN domain_NN >_NN extracellular_NN domain_NN >_NN
          distal_NN cytoplasmic_JJ domain_NN (_( Table_NNP 2_CD ,_, Figure_NN 4_LS )_) ._.
        
      
      
        Discussion_NNP
        The_DT pathway_NN by_IN which_WDT LPS_NNP activates_NNS host_NN innate_JJ immune_JJ
        defenses_NNS has_VBZ been_VBN illuminated_JJ by_IN the_DT positional_JJ cloning_VBG of_IN 
        Lps_NNP and_CC establishment_NN of_IN its_PRP$ identity_NN
        with_IN 
        Tlr_NNP 4_CD [_NN 11_CD ]_NN ,_, a_DT mammalian_JJ
        representative_NN of_IN an_DT ancient_JJ family_NN of_IN receptors_NNS [_NN 16_CD ]_NN that_WDT
        serve_VBP both_DT developmental_NN and_CC defensive_JJ functions_NNS ._. The_DT
        function_NN of_IN Tlr_NNP 4_CD as_IN the_DT LPS_NNP signal_NN transducer_NN became_VBD clear_JJ
        when_WRB mapping_NN [_NN 10_CD ]_NN and_CC sequencing_VBG [_NN 11_CD ]_NN data_NNS revealed_VBD 
        Tlr_NNP 4_CD as_IN the_DT only_JJ gene_NN in_IN a_DT critical_JJ
        2_CD ._. 6_CD megabase_NN (_( Mb_NNP )_) region_NN and_CC ,_, furthermore_RB ,_, showed_VBD that_IN two_CD
        strains_NNS of_IN LPS-resistant_NNP mice_NNS are_VBP homozygous_JJ for_IN mutations_NNS
        of_IN 
        Tlr_NNP 4_CD that_WDT are_VBP absent_JJ in_IN closely_RB
        related_VBN LPS-sensitive_NNP strains_NNS ._.
        In_IN 
        Drosophila_NNP ,_, the_DT prototypic_JJ homolog_NN
        of_IN the_DT mammalian_JJ Toll-like_NNP receptors_NNS (_( Toll_NNP )_) defends_VBZ against_IN
        fungal_NN infection_NN [_NN 18_CD ]_NN ,_, whereas_IN the_DT protein_NN 18_CD -_: wheeler_NN
        defends_VBZ against_IN bacterial_JJ infection_NN [_NN 19_CD ]_NN ._. In_IN the_DT case_NN of_IN
        Toll_NNP ,_, there_EX is_VBZ no_DT evidence_NN of_IN direct_JJ contact_NN between_IN the_DT
        receptor_NN and_CC the_DT microbial_NN pathogen_NN or_CC its_PRP$ components_NNS ._.
        Rather_RB ,_, infection_NN activates_NNS a_DT proteolytic_JJ cascade_NN that_WDT
        leads_VBZ to_TO the_DT production_NN of_IN an_DT endogenous_JJ ligand_NN (_( SpÃ_NNP ¤_NN tzle_NN )_) ,_,
        which_WDT in_IN turn_NN engages_VBZ Toll_NNP ._. The_DT situation_NN is_VBZ apparently_RB
        different_JJ in_IN mammals_NNS ,_, in_IN which_WDT Tlr_NNP 4_CD is_VBZ clearly_RB a_DT direct_JJ
        interface_NN with_IN the_DT microbial_NN world_NN ._. As_IN such_JJ ,_, the_DT primary_JJ
        structure_NN of_IN a_DT Tlr_NNP 4_CD molecule_NN determines_VBZ ligand_NN specificity_NN
        [_NN 13_CD ]_NN ,_, accounting_NN for_IN the_DT well-known_JJ observation_NN that_IN mouse_NN
        cells_NNS can_MD recognize_VB tetra-acyl_JJ lipid_NN A_DT as_IN an_DT agonist_NN [_NN 20_CD ]_NN
        whereas_IN human_JJ cells_NNS recognize_VBP it_PRP as_IN an_DT antagonist_NN [_NN 20_CD ,_, 21_CD ,_,
        22_CD ,_, 23_CD ,_, 24_CD ]_NN ._.
        As_IN mice_NNS of_IN the_DT C_NNP 3_CD H_NNP /_NN HeJ_NNP strain_NN are_VBP highly_RB susceptible_JJ to_TO
        infection_NN by_IN Gram-negative_NNP bacteria_NNS ,_, it_PRP would_MD seem_VB
        plausible_JJ that_IN among_IN human_JJ patients_NNS with_IN Gram-negative_NNP
        sepsis_NN ,_, some_DT individuals_NNS may_MD have_VB been_VBN at_IN risk_NN by_IN virtue_NN of_IN
        mutations_NNS in_IN 
        TLR_NNP 4_CD ._. The_DT first_JJ step_NN in_IN determining_VBG
        whether_IN different_JJ isoforms_NNS of_IN Tlr_NNP 4_CD confer_VB added_VBD risk_NN of_IN ,_, or_CC
        protection_NN against_IN ,_, sepsis_NN is_VBZ the_DT assessment_NN of_IN genetic_JJ
        variability_NN at_IN this_DT locus_JJ in_IN the_DT normal_JJ population_NN ._.
        Whereas_IN ablative_JJ mutations_NNS of_IN 
        Tlr_NNP 4_CD abolish_VB the_DT capacity_NN to_TO detect_VB
        LPS_NNP ,_, the_DT question_NN arises_VBZ as_IN to_TO whether_IN less_RBR severe_JJ mutation_NN
        might_MD alter_VB either_CC the_DT specificity_NN of_IN LPS_NNP detection_NN ,_, as_IN
        discussed_VBN above_IN ,_, or_CC the_DT magnitude_NN of_IN the_DT LPS_NNP signal_NN ._. Our_PRP$
        present_JJ knowledge_NN of_IN Tlr_NNP 4_CD structural_JJ variation_NN in_IN mice_NNS may_MD
        permit_VB an_DT answer_NN to_TO this_DT question_NN ,_, insofar_RB as_IN the_DT mutations_NNS
        might_MD easily_RB be_VB recreated_JJ ,_, and_CC measurements_NNS of_IN
        signal-transducing_JJ activity_NN through_IN the_DT modified_VBN receptors_NNS
        carried_VBD out_IN in_IN immortalized_JJ C_NNP 3_CD H_NNP /_NN HeJ_NNP macrophages_NNS [_NN 13_CD ]_NN ._.
        Animals_NNS of_IN the_DT A_DT /_NN J_NNP and_CC P_NN /_NN J_NNP strains_NNS have_VBP defective_JJ
        tumoricidal_NN capacity_NN [_NN 25_CD ,_, 26_CD ,_, 27_CD ,_, 28_CD ,_, 29_CD ]_NN ,_, although_IN in_IN
        neither_DT case_NN is_VBZ the_DT 
        Lps_NNP locus_JJ implicated_VBN in_IN the_DT
        defect_NN ._.
        Deleterious_NNP mutations_NNS of_IN 
        TLR_NNP 4_CD might_MD reasonably_RB be_VB sought_VBN in_IN
        individuals_NNS who_WP have_VBP developed_VBN serious_JJ Gram-negative_NNP
        infections_NNS ,_, on_IN the_DT premise_NN that_IN mice_NNS with_IN deleterious_JJ
        mutations_NNS of_IN 
        Tlr_NNP 4_CD are_VBP rendered_VBN susceptible_JJ to_TO such_JJ
        infections_NNS ._. Similarly_RB ,_, in_IN birds_NNS ,_, a_DT polymorphism_NN at_IN the_DT 
        tenascin_NN locus_JJ (_( which_WDT lies_VBZ a_DT few_JJ
        megabases_NNS proximal_NN to_TO 
        Tlr_NNP 4_CD in_IN mice_NNS )_) predicts_VBZ susceptibility_NN
        to_TO Gram-negative_NNP infection_NN [_NN 30_CD ]_NN ,_, suggesting_VBG that_IN it_PRP may_MD
        lie_VB in_IN linkage_NN disequilibrium_NN with_IN a_DT particular_JJ form_NN of_IN the_DT
        avian_NN 
        Tlr_NNP 4_CD gene_NN ._. Beyond_IN this_DT ,_, it_PRP may_MD be_VB
        assumed_VBN ,_, given_VBN the_DT powerful_JJ pro-inflammatory_JJ activity_NN of_IN
        the_DT receptor_NN ,_, that_DT germline_NN or_CC somatic_JJ mutations_NNS of_IN 
        TLR_NNP 4_CD could_MD in_IN some_DT instances_NNS cause_VBP
        constitutive_JJ signal_NN transduction_NN (_( as_IN observed_VBN with_IN the_DT 
        Drosophila_NNP Toll_NNP locus_JJ [_NN 31_CD ]_NN )_) ._. such_JJ
        mutations_NNS might_MD ,_, in_IN principle_NN ,_, account_NN for_IN certain_JJ
        inflammatory_JJ diseases_NNS ._. In_IN fact_NN ,_, in_IN the_DT 
        Lpr_NNP model_NN of_IN systemic_JJ lupus_JJ
        erythematosus_JJ ,_, the_DT 
        Lps_NNP locus_JJ was_VBD believed_VBN a_DT likely_JJ
        modulator_NN of_IN phenotype_NN [_NN 32_CD ]_NN ._. This_DT would_MD seem_VB still_RB more_RBR
        likely_JJ at_IN present_JJ ,_, given_VBN the_DT paucity_NN of_IN other_JJ candidate_NN
        genes_NNS in_IN the_DT immediate_JJ vicinity_NN of_IN 
        Tlr_NNP 4_CD [_NN 10_CD ]_NN ._.
        The_DT evolutionary_JJ conservation_NN of_IN 
        Tlr_NNP 4_CD is_VBZ of_IN particular_JJ interest_NN ,_, in_IN
        that_DT different_JJ species_NNS show_VBP preferential_JJ responses_NNS to_TO some_DT
        LPS_NNP forms_NNS and_CC not_RB others_NNS [_NN 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ,_, 24_CD ]_NN ,_, and_CC have_VBP
        particular_JJ '_POS set_VBN points_NNS '_POS for_IN responses_NNS to_TO toxic_JJ LPS_NNP
        molecules_NNS ._. An_DT assessment_NN of_IN variability_NN may_MD be_VB made_VBN through_IN
        comparison_NN of_IN different_JJ species_NNS ,_, but_CC is_VBZ complemented_JJ by_IN the_DT
        study_NN of_IN a_DT large_JJ number_NN of_IN individuals_NNS within_IN species_NNS ._. Both_DT
        approaches_NNS reveal_VBP that_IN the_DT extracellular_NN domain_NN of_IN Tlr_NNP 4_CD is_VBZ
        highly_RB variable_JJ compared_VBN with_IN the_DT transmembrane_NN domain_NN and_CC
        proximal_NN cytoplasmic_JJ domain_NN of_IN the_DT protein_NN ._. Pooling_NNP the_DT
        number_NN of_IN mutable_JJ sites_NNS in_IN the_DT extracellular_NN domain_NN and_CC
        transmembrane_NN domain_NN of_IN humans_NNS and_CC mice_NNS ,_, 17_CD coding_VBG changes_NNS
        are_VBP observed_VBN ,_, compared_VBN with_IN two_CD in_IN the_DT proximal_NN cytoplasmic_JJ
        domain_NN ._. Moreover_RB ,_, variability_NN does_VBZ not_RB seem_VB confined_VBN to_TO any_DT
        particular_JJ region_NN of_IN the_DT extracellular_NN domain_NN ,_, but_CC is_VBZ
        spread_VBN uniformly_RB across_IN its_PRP$ length_NN ._.
        The_DT extracellular_NN domain_NN of_IN any_DT receptor_NN is_VBZ concerned_VBN
        principally_RB with_IN ligand_NN recognition_NN ._. Given_VBN that_IN the_DT ligand_NN
        is_VBZ an_DT endogenous_JJ protein_NN ,_, extracellular_NN domain_NN conservation_NN
        tends_VBZ to_TO be_VB strict_JJ ,_, insofar_RB as_IN mutations_NNS affecting_VBG
        extracellular_NN domain_NN structure_NN are_VBP likely_JJ to_TO diminish_VB
        specificity_NN or_CC affinity_NN of_IN binding_JJ ._. Hence_RB ,_, protein-binding_JJ
        receptors_NNS tend_VBP to_TO be_VB minimally_RB polymorphic_JJ ._. The_DT presumed_VBN
        ligand_NN for_IN Tlr_NNP 4_CD is_VBZ LPS_NNP itself_PRP ,_, presented_VBD alone_RB or_CC in_IN
        conjunction_NN with_IN another_DT protein_NN (_( for_IN example_NN CD_NNP 14_CD )_) [_NN 13_CD ]_NN ,_,
        and_CC the_DT relatively_RB high_JJ frequency_NN of_IN polymorphism_NN observed_VBD
        in_IN Tlr_NNP 4_CD may_MD be_VB viewed_VBN as_IN a_DT consequence_NN of_IN the_DT protective_JJ
        effect_NN rendered_VBN by_IN LPS_NNP recognition_NN and_CC the_DT variability_NN of_IN
        LPS_NNP structure_NN ._.
        The_DT cytoplasmic_JJ domain_NN of_IN Tlr_NNP 4_CD is_VBZ far_RB more_RBR stringently_RB
        conserved_JJ than_IN the_DT extracellular_NN domain_NN ._. This_DT is_VBZ probably_RB
        due_JJ to_TO the_DT fact_NN that_IN the_DT cytoplasmic_JJ domain_NN of_IN Tlr_NNP 4_CD is_VBZ not_RB
        required_VBN to_TO cope_VB with_IN a_DT ligand_NN of_IN variable_JJ structure_NN ._.
        Rather_RB ,_, when_WRB called_VBN upon_IN to_TO signal_VB ,_, it_PRP must_MD do_VB so_RB ,_,
        utilizing_VBG transducing_VBG molecules_NNS with_IN conserved_JJ structures_NNS ._.
        On_IN the_DT other_JJ hand_NN ,_, the_DT intensity_NN of_IN the_DT LPS_NNP signal_NN has_VBZ
        apparently_RB been_VBN optimized_JJ for_IN each_DT species_NNS [_NN 33_CD ]_NN ,_, perhaps_RB
        ensuring_VBG that_IN the_DT response_NN to_TO LPS_NNP is_VBZ appropriately_RB
        integrated_VBN into_IN the_DT immune_JJ response_NN as_IN a_DT whole_NN ._. Humans_NNP ,_,
        ungulates_NNS and_CC rabbits_NNS ,_, for_IN example_NN ,_, exhibit_NN an_DT intense_JJ
        response_NN to_TO low_JJ concentrations_NNS of_IN LPS_NNP ,_, whereas_IN the_DT lower_JJR
        primates_NNS and_CC most_JJS rodents_NNS are_VBP relatively_RB more_RBR resistant_JJ [_NN
        4_CD ]_NN ._. The_DT highly_RB variable_JJ carboxy-terminal_JJ end_NN of_IN the_DT Tlr_NNP 4_CD
        cytoplasmic_JJ domain_NN may_MD be_VB seen_VBN as_IN the_DT embodiment_NN of_IN
        interspecific_JJ differences_NNS in_IN LPS_NNP sensitivity_NN ,_, although_IN the_DT
        poor_JJ conservation_NN of_IN this_DT portion_NN of_IN the_DT molecule_NN might_MD
        alternatively_RB be_VB taken_VBN to_TO indicate_VB a_DT neutral_JJ effect_NN of_IN
        mutation_NN ._. It_PRP is_VBZ also_RB possible_JJ that_IN this_DT region_NN of_IN the_DT
        molecule_NN is_VBZ subject_JJ to_TO a_DT higher_JJR rate_NN of_IN mutation_NN than_IN that_DT
        applying_VBG to_TO the_DT rest_NN of_IN the_DT protein_NN ._. Although_IN most_JJS such_JJ
        mutations_NNS might_MD be_VB removed_VBN by_IN selection_NN ,_, some_DT might_MD be_VB
        discovered_VBN in_IN populations_NNS defined_VBN by_IN the_DT occurrence_NN of_IN
        Gram-negative_NNP sepsis_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Determination_NNP of_IN the_DT complete_JJ mouse_NN (_( Tlr_NNP 4_LS )_) and_CC
          human_JJ (_( TLR_NNP 4_LS )_) genomic_JJ sequences_NNS
          The_DT mouse_NN bacterial_JJ artificial_JJ chromosome_NN (_( BAC_NNP )_) 152_CD C_NNP 16_CD
          (_( from_IN the_DT 129_CD /_NN J_NNP strain_NN ,_, Research_NNP Genetics_NNP )_) was_VBD previously_RB
          shown_VBN by_IN us_PRP to_TO contain_VB the_DT 
          Tlr_NNP 4_CD gene_NN in_IN its_PRP$ entirety_NN [_NN 10_CD ]_NN ,_,
          and_CC a_DT small_JJ fraction_NN of_IN 
          Tlr_NNP 4_CD was_VBD also_RB found_VBN in_IN the_DT
          overlapping_VBG BAC_NNP 309_CD I_PRP 17_CD [_NN 10_CD ]_NN ._. Human_NNP 
          TLR_NNP 4_CD was_VBD identified_VBN in_IN BAC_NNP 110_CD P_NN 15_CD
          (_( Genome_NNP Systems_NNPS )_) by_IN hybridization_NN screening_NN using_VBG a_DT
          PCR-amplified_NNP human_JJ TLR_NNP 4_CD cDNA_NN sequence_NN as_IN a_DT probe_NN ._. All_DT
          three_CD BACs_NNP were_VBD fragmented_VBN by_IN ultrasound_NN ,_, shotgun_NN cloned_VBN
          into_IN the_DT vector_NN pBluescript-KS_JJ ,_, and_CC extensively_RB sequenced_JJ
          using_VBG ABI_NNP model_NN 373_CD and_CC 377_CD sequencers_NNS ,_, using_VBG Big_NNP Dye_NNP
          terminators_NNS ;_: 959_CD reads_VBZ were_VBD obtained_VBN from_IN 390_CD I_PRP 17_CD ,_, 1503_CD
          reads_VBZ from_IN 110_CD P_NN 15_CD ,_, and_CC 2731_CD reads_VBZ from_IN 152_CD C_NNP 16_CD ._. The_DT
          average_JJ read_NN length_NN was_VBD approximately_RB 700_CD nucleotides_NNS ._. To_TO
          concentrate_VB data_NNS acquisition_NN efforts_NNS on_IN the_DT 
          Tlr_NNP 4_CD and_CC 
          TLR_NNP 4_CD genes_NNS themselves_PRP ,_, PCR_NNP primers_NNS
          were_VBD fashioned_VBN to_TO match_VB regions_NNS flanking_VBG each_DT gene_NN ._. A_DT 16_CD
          kb_NN fragment_NN was_VBD amplified_VBN from_IN the_DT mouse_NN BAC_NNP 152_CD C_NNP 16_CD ,_, and_CC
          a_DT 12_CD kb_NN fragment_NN was_VBD amplified_VBN from_IN the_DT human_JJ BAC_NNP 110_CD P_NN 15_CD ,_,
          each_DT containing_VBG all_DT exons_NNS of_IN the_DT respective_JJ gene_NN ._. These_DT
          fragments_NNS were_VBD also_RB shotgun_NN cloned_VBN and_CC extensively_RB
          sequenced_JJ ,_, so_IN that_IN the_DT depth_NN of_IN sequence_NN reached_VBD an_DT
          average_NN of_IN 12_CD reads_VBZ over_IN the_DT area_NN of_IN greatest_JJS interest_NN ._.
          Sequence_NNP assembly_NN used_VBD the_DT programs_NNS phred_JJ and_CC Phrap_NNP
          (_( obtained_VBN from_IN Brent_NNP Ewing_NNP and_CC Phil_NNP Green_NNP ,_, University_NNP of_IN
          Washington_NNP Genome_NNP Center_NNP )_) ._. Interpretation_NNP of_IN repetitive_JJ
          elements_NNS was_VBD achieved_VBN with_IN the_DT program_NN RepeatMasker_NNP
          (_( obtained_VBN from_IN Arian_NNP Smit_NNP ,_, University_NNP of_IN Washington_NNP
          Genome_NNP Center_NNP )_) ._. A_DT contiguous_JJ high-quality_JJ sequence_NN 18_CD ,_, 974_CD
          bp_NN in_IN length_NN ,_, containing_VBG 
          TLR_NNP 4_CD ,_, was_VBD obtained_VBN from_IN the_DT human_JJ
          BAC_NNP ,_, and_CC a_DT contig_NN 91_CD ,_, 748_CD bp_NN in_IN length_NN ,_, containing_VBG 
          Tlr_NNP 4_CD ,_, was_VBD obtained_VBN from_IN the_DT mouse_NN
          BAC_NNP ._. Over_IN these_DT intervals_NNS ,_, the_DT error_NN rate_NN was_VBD estimated_VBN
          at_IN <_NN 1_CD per_IN 10_CD 4_CD bp_NN ._. These_DT sequences_NNS have_VBP been_VBN posted_VBN to_TO
          GenBank_NNP in_IN annotated_JJ form_NN (_( accession_NN number_NN AF_NNP 177767_CD for_IN
          the_DT murine_NN sequence_NN and_CC AF_NNP 177765_CD for_IN the_DT human_JJ sequence_NN )_) ._.
          All_DT data_NNS related_VBN to_TO mutations_NNS are_VBP presented_VBN with_IN
          reference_NN to_TO these_DT sequences_NNS ._.
        
        
          Sequencing_NNP DNA_NNP from_IN mouse_NN ,_, chimpanzee_NN and_CC baboon_NN
          samples_NNS
          Mouse_NNP DNA_NNP ,_, obtained_VBN from_IN animals_NNS of_IN 35_CD 
          Mus_NNP musculus_JJ strains_NNS ,_, was_VBD ordered_VBN
          from_IN the_DT Jackson_NNP Laboratories_NNPS ._. Chimpanzee_NNP and_CC baboon_NN DNA_NNP
          were_VBD obtained_VBN from_IN Kurt_NNP Benirschke_NNP (_( University_NNP of_IN
          California_NNP ,_, San_NNP Diego_NNP )_) and_CC Gregory_NNP Delzoppo_NNP (_( Scripps_NNP
          Research_NNP Institute_NNP )_) ,_, respectively_RB ._.
          The_DT three_CD principal_JJ exons_NNS of_IN 
          Tlr_NNP 4_CD were_VBD amplified_VBN independently_RB
          from_IN mouse_NN genomic_JJ DNA_NNP samples_NNS ,_, leaving_VBG a_DT margin_NN of_IN
          approximately_RB 50_CD bp_NN to_TO each_DT side_NN of_IN the_DT exons_NNS so_RB as_IN to_TO
          indentify_NN intronic_JJ mutations_NNS that_WDT might_MD alter_VB splicing_VBG ._.
          All_DT exons_NNS of_IN the_DT chimpanzee_NN were_VBD amplified_VBN and_CC sequenced_JJ
          using_VBG the_DT same_JJ primers_NNS used_VBN to_TO amplify_VB and_CC sequence_NN the_DT
          human_JJ exons_NNS ._. For_IN the_DT baboon_NN ,_, the_DT first_JJ two_CD exons_NNS were_VBD
          also_RB amplified_VBN using_VBG these_DT same_JJ primers_NNS ;_: however_RB ,_, the_DT
          third_JJ exon_NN of_IN the_DT baboon_NN was_VBD amplified_VBN with_IN a_DT substituted_VBN
          primer_NN at_IN the_DT 5_CD '_POS end_NN ._.
          The_DT PCR_NNP products_NNS were_VBD isolated_VBN by_IN agarose_NN gel_NN
          electrophoresis_NNS ._. Exons_NNP 1_CD and_CC 2_CD were_VBD sequenced_JJ using_VBG the_DT
          same_JJ primers_NNS that_WDT were_VBD used_VBN for_IN amplification_NN ._. Exon_NNP 3_CD was_VBD
          sequenced_JJ using_VBG the_DT flanking_VBG primers_NNS as_RB well_RB as_IN a_DT
          collection_NN of_IN eight_CD internal_JJ primers_NNS ._. In_IN this_DT manner_NN ,_, the_DT
          entire_JJ coding_VBG region_NN and_CC all_DT splice_NN junctions_NNS of_IN 
          Tlr_NNP 4_CD could_MD be_VB covered_VBN with_IN a_DT total_NN
          of_IN 14_CD sequencing_VBG reads_VBZ ._. All_DT primers_NNS used_VBN for_IN
          amplification_NN and_CC sequencing_VBG are_VBP presented_VBN in_IN Table_NNP 3_CD ;_:
          separate_JJ sets_NNS were_VBD used_VBN to_TO amplify_VB and_CC sequence_NN mouse_NN and_CC
          the_DT primate_NN samples_NNS ._.
          Independent_JJ assembly_NN of_IN each_DT sample_NN was_VBD required_VBN as_IN a_DT
          condition_NN for_IN further_JJ analysis_NN ,_, and_CC if_IN such_JJ assembly_NN
          failed_VBD ,_, additional_JJ reads_VBZ were_VBD executed_VBN using_VBG a_DT secondary_JJ
          collection_NN of_IN primers_NNS ._. Thereafter_RB ,_, mutations_NNS were_VBD
          identified_VBN 
          en_IN masse_FW ,_, by_IN pooling_VBG all_DT of_IN the_DT
          reads_VBZ from_IN 25_CD to_TO 30_CD samples_NNS at_IN a_DT time_NN and_CC reassembling_VBG
          with_IN the_DT program_NN polyphred_JJ ,_, using_VBG the_DT phred-_NN PhrapPoly_NNP
          script_NN (_( obtained_VBN from_IN Natalie_NNP Kolker_NNP ,_, University_NNP of_IN
          Washington_NNP Genome_NNP Center_NNP )_) ._. Consed_NNP 
          -_: alpha_NN (_( obtained_VBN from_IN David_NNP Gordon_NNP ,_,
          University_NNP of_IN Washington_NNP Genome_NNP Center_NNP )_) was_VBD used_VBN to_TO
          visualize_VB reads_VBZ and_CC mutations_NNS ._.
          The_DT annotated_JJ chimpanzee_NN exon_NN sequences_NNS have_VBP been_VBN
          submitted_VBN to_TO GenBank_NNP with_IN the_DT accession_NN numbers_NNS AF_NNP 179218_CD ,_,
          AF_NNP 179219_CD and_CC AF_NNP 179220_CD ._. The_DT baboon_NN sequences_NNS have_VBP been_VBN
          submitted_VBN with_IN the_DT accession_NN numbers_NNS AF_NNP 180962_CD ,_, AF_NNP 180963_CD
          and_CC AF_NNP 180694_CD ._. For_IN genetic_JJ comparisons_NNS ,_, rat_NN (_( Genbank_NNP
          AF_NNP 057025_CD )_) and_CC hamster_NN (_( AF_NNP 153676_CD )_) 
          Tlr_NNP 4_CD sequences_NNS were_VBD also_RB used_VBN ._.
        
        
          Genetic_JJ computation_NN
          A_DT 500_CD MHz_NNP DEC-alpha_NNP system_NN equipped_VBN with_IN 256_CD Mbytes_NNP of_IN
          memory_NN was_VBD used_VBN for_IN direct_JJ analysis_NN of_IN sequence_NN data_NNS as_IN
          described_VBN above_IN ._. In_IN addition_NN to_TO the_DT programs_NNS already_RB
          mentioned_VBN ,_, the_DT GCG_NNP software_NN (_( version_NN 9_CD ._. 0_CD )_) was_VBD used_VBN for_IN
          alignment_NN analysis_NN ,_, with_IN the_DT program_NN Pileup_NNP used_VBD in_IN
          multiple_JJ alignments_NNS of_IN protein_NN sequences_NNS ._. The_DT
          windows-based_JJ program_NN Generunner_NNP 3_CD ._. 0_CD (_( Hastings_NNP Software_NNP )_)
          was_VBD used_VBN for_IN the_DT design_NN of_IN oligonucleotide_NN primers_NNS ._. A_DT
          spline_NN curve_NN describing_VBG heterogeneity_NN of_IN the_DT Tlr_NNP 4_CD
          polypeptide_NN sequence_NN from_IN different_JJ species_NNS was_VBD produced_VBN
          using_VBG the_DT program_NN Prism_NNP 3_CD ._. 0_CD (_( Graphpad_NNP Software_NNP )_) ._.
          Sequences_NNP were_VBD prepared_VBN for_IN submission_NN with_IN the_DT use_NN of_IN
          the_DT program_NN Sequin_NNP 2_CD ._. 90_CD (_( obtained_VBN from_IN the_DT National_NNP
          Center_NNP for_IN Biotechnological_NNP Information_NNP )_) ._.
        
      
    
  
